Document is current
Any future updates will be listed below
-
Authors
Rahmani, Nora E.
Ramachandra, Nandini
Sahu, Srabani
Gitego, Nadege
Lopez, Andrea
Pradhan, Kith
Bhagat, Tushar D.
Gordon-Mitchell, Shanisha
Pena, Bianca Rivera https://orcid.org/0000-0001-8821-0210
Kazemi, Mohammad
Rao, Keshav
Giricz, Orsi https://orcid.org/0000-0002-1328-3682
Maqbool, Shahina Bano
Olea, Raul
Zhao, Yongmei
Zhang, Jinghang https://orcid.org/0000-0003-1436-6460
Dolatshad, Hamid https://orcid.org/0000-0002-4724-1720
Tittrea, Vickram
Tatwavedi, Dharamveer
Singh, Shalini
Lee, Juseong
Sun, Tianyu https://orcid.org/0000-0002-8245-0771
Steidl, Ulrich
Shastri, Aditi https://orcid.org/0000-0002-5366-8288
Inoue, Daichi
Abdel-Wahab, Omar
Pellagatti, Andrea https://orcid.org/0000-0002-6122-0221
Gavathiotis, Evripidis https://orcid.org/0000-0001-6319-8331
Boultwood, Jacqueline https://orcid.org/0000-0002-4330-2928
Verma, Amit https://orcid.org/0000-0001-7592-7693
- License Information
-
More Information
Article History
Received: 8 February 2021
Revised: 23 February 2021
Accepted: 16 March 2021
First Online: 21 September 2021
Competing interests
: Amit Verma has received research funding from GSK, Incyte, Medpacto, and Eli Lilly and is a scientific advisor for Stelexis, Novartis, Acceleron, and Celgene. The remaining authors declare no competing interests.
